ALX Oncology Holdings Inc.

ALXO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$22-$26-$31-$29
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$0$5$6
Change in WC$2-$3$1-$9
Other Non-Cash$0$6$0-$0
Operating Cash Flow-$17-$23-$25-$32
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$4-$25-$16-$4
Inv. Sales/Matur.$26$48$43$38
Other Inv. Act.$0$0$0$0
Investing Cash Flow$21$22$28$33
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$0$0$0-$29
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$30
Financing Cash Flow-$0-$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash$4-$1$3$1
Supplemental Information
Beg. Cash$19$21$18$16
End Cash$24$19$21$18
Free Cash Flow-$17-$23-$25-$32